Testosterone Therapy Is Booming. But Is It Actually Safe?
As more men turn to testosterone replacement therapy (TRT) for energy, mood and muscle, experts warn the risks are still not fully understood.
This episode was made possible by the support of Yakult and produced independently by Scientific American’s board of editors.
Rachel Feltman: For Scientific American’s Science Quickly, I’m Rachel Feltman.
Whether it’s framed as a cure-all for fatigue and low libido or a shortcut to gaining muscle mass, testosterone replacement therapy, or TRT, is all over the Internet these days. But how much of the hype is actually backed by science?
If you’re enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
Here to help us make sense of the testosterone boom is Stephanie Pappas, a freelance reporter based in Colorado. Stephanie recently covered the growing popularity—and availability—of TRT for Scientific American.
Thanks so much for coming on to chat.
Stephanie Pappas: Thank you.
Feltman: So you recently wrote about testosterone replacement therapy for Scientific American. For folks who are not on the right part of the Internet to have heard all about this—or maybe staying off the wrong parts [laughs] of the Internet, depending on your perspective—what’s going on with TRT right now?
Pappas: Well, testosterone replacement therapy has become extremely popular. It has been something that’s been in the background for many, many years. Synthetic testosterone was first invented in 1935, but for a long, long time people thought that testosterone replacement, if it was used for any kind of symptoms men might be having, that it could cause prostate cancer. And then it was believed, perhaps, it could cause heart disease or cardiovascular events like a stroke or a heart attack.
As it turns out the last few years we found that it doesn’t really cause these really serious events. However, a lot less is known about the long-term health impacts. People are really flocking to TRT largely as a result of word of mouth. There are a lot of private clinics that offer this out of pocket, so you don’t have to have an insurance company agree that you need it. And people on social media are using it for just a litany of different symptoms, and it can be anything from muscle-building to fatigue to mood problems and irritability, and it’s kind of being pitched as a cure-all for a lot of different things.
Feltman: And what evidence is there for the benefits of testosterone replacement therapy, maybe starting with people who actually have low testosterone?
Pappas: Yeah, so there is such a thing as low testosterone. No one exactly agrees on what the cutoff is, and probably that’s because there’s a lot of variability in our hormones—like, anyone who’s ever tried any sort of hormone treatment, including birth control or HRT [hormone replacement therapy], can tell you that people respond really differently.
So for men who really do have low testosterone, the evidence suggests that you can see some benefits in mood if you have major depression. You may see some improvements in energy. The most well-established result from the studies of TRT is that you’ll probably see a little boost in libido if you have low testosterone and you now start taking TRT, and that’s because testosterone works in the brain to increase sexual desire.
Feltman: Hmm.
Pappas: For men who don’t have low testosterone, which are many of the men who are now getting treatment, the evidence for benefits is much, much lower. We don’t know if you really see much besides additional muscle-building abilities.
Feltman: And what are the potential downsides? You mentioned that one of the reasons there’s such a boom right now is that research has showed that the connection to prostate cancer is not concerning the way we once thought it was. But what about other issues that can come up when you don’t have low testosterone and you start taking a bunch of testosterone?
Feltman: Right, and, you know, not that this is the reason that’s upsetting, but there is also kind of an irony there because a lot of the marketing is sort of stereotypical masculinity, so it’s not surprising that people are caught off guard by that potential downside.
Feltman: When you say that regaining fertility after these treatments can be complex and slow, could you walk us through what you mean by that?
Pappas: Sure, because your own testosterone levels and sperm production drop, you’re going to have to, usually, get off the testosterone. That can really lead to a hormone crash; since your body is, really, at that point in quite low testosterone, you may feel irritable, you may feel fatigue. So you’re gonna have to go through that—a bit of a roller coaster.
Feltman: Yeah, so let’s talk some more about those freestanding clinics. You know, in addition to TRT, you know, being more in demand and more in the conversation, it also seems like it’s more accessible than ever, so what are some of the sort of concerning characteristics of these clinics that are popping up?
Pappas: Well, you don’t wanna paint all clinics with the same brush …
Feltman: Sure.
The recommendations from professional societies suggest you get two testosterone tests on different days because testosterone levels swing wildly. I could not find anyone who’d reported to me that they’d gotten two tests. I can’t say that there aren’t clinics that do it. Typically you’re gonna get one test. Typically they are motivated to prescribe what they can to you.
The problem, often, is that because of this long-term fear around testosterone, is that many primary care doctors are nervous about prescribing it or don’t feel that they’ve been trained. I spoke to one man who, actually, his doctor said, “Yes, your testosterone is undeniably low, but I don’t know what to do about it. Maybe just go to one of these clinics, and they can help you.”
His experience in that clinic, unfortunately, was that they kind of gave him a generic prescription, did not really test through his levels, didn’t really talk through, you know, alternative treatments or other things he might look at doing. So he felt his loss and he ended up looking on Reddit for advice, which, as we all know [laughs], is a real hit-and-miss proposition …
Feltman: Sure.
Pappas: So men are often kind of left searching for their own information, and they may not have good sources of information.
Feltman: And the experts that you spoke to, what do they wanna see change about the way we’re treating TRT?
Pappas: The first step is that a lot of physicians who specialize in hormone replacement therapy for men would like to see more awareness among primary care physicians and other doctors that men might go to, because if they could coordinate that care in a really responsible way, there are probably many men who could benefit: they do have low testosterone but haven’t ever thought about being tested.
And then the other side of this is just patient education. If you’re going to consider going to a clinic, don’t just go somewhere that will happily hand you a prescription. Really look for someone who is going to sit down with you, who is going to talk through lifestyle changes, who’s going to look at alternative problems. So one doctor I spoke to said, “The first thing we do is we look for sleep apnea in our patients. If we can cure that, oftentimes we don’t need to look at their testosterone levels again.”
And don’t be in a rush to walk out that first day with a prescription that might be too high for you and might lead to side effects like acne, or another side effect you can see is an overgrowth of red blood cells that can lead you to need to have to donate blood every month to keep that in normal range. Look for something that’s not going to cause the side effects that can really affect your life in the long term.
Feltman: Sure, well, thank you so much for coming on to talk us through your feature. I really appreciate it.
Pappas: Thank you so much.
Feltman: That’s all for today’s episode. You can read Stephanie’s full story on TRT in the July/August issue of Scientific American.
We’ll be back next week with something special: a three-part miniseries on bird flu. From avian influenza’s wild origins to its spread across U.S. farms to the labs trying to keep it from becoming the next pandemic, this looming public health threat has a lot of moving parts, but we’ll get you all caught up.
For Scientific American, this is Rachel Feltman. Have a great weekend!
Rachel Feltman is former executive editor of Popular Science and forever host of the podcast The Weirdest Thing I Learned This Week. She previously founded the blog Speaking of Science for the Washington Post.
Stephanie Pappas is a freelance science journalist based in Denver, Colo.
Fonda Mwangi is a multimedia editor at Scientific American. She previously worked as an audio producer at Axios, The Recount and WTOP News. She holds a master’s degree in journalism and public affairs from American University in Washington, D.C.
Alex Sugiura is a Peabody and Pulitzer Prize–winning composer, editor and podcast producer based in Brooklyn, N.Y. He has worked on projects for Bloomberg, Axios, Crooked Media and Spotify, among others.
Source: www.scientificamerican.com